SREBF1 and diabetic kidney disease: Increased SREBP-1 levels were reported in a study performed on rats with DKD, stating the role of SREBP-1 mediated lipid deposition, that contributes to tubulointerstitial fibrosis, glomerulosclerosis and albuminuria (47).